Assessment of stereotactic radiosurgery for intradural backbone tumors.
CNS Oncol. 2017 Apr;6(2):131-138
Authors: Purvis TE, Goodwin CR, Lubelski D, Laufer I, Sciubba DM
Stereotactic radiosurgery (SRS) has change into an more and more well-liked therapy modality for spinal tumors resulting from its noninvasive and focused strategy. Whether or not SRS has the promise of relieving pretreatment signs and offering native tumor management for sufferers with intradural backbone tumors remains to be debated. This overview explores the present literature on SRS therapy for each metastatic and benign intradural tumors, with a give attention to differential use for intramedullary and intradural extramedullary neoplasms. Though mortality charges from underlying malignant illness stay excessive, SRS could profit sufferers with spinal metastatic lesions. Benign tumors have proven a promising response to SRS remedy with low charges of issues. Bigger research are needed to find out the indications and final result profile of SRS for intradural spinal neoplasms.
PMID: 28425771 [PubMed – indexed for MEDLINE]